234 related articles for article (PubMed ID: 16712455)
41. Antimicrobial properties of amine- and guanidine-functionalized derivatives of betulinic, ursolic and oleanolic acids: Synthesis and structure/activity evaluation.
Spivak AY; Khalitova RR; Nedopekina DA; Gubaidullin RR
Steroids; 2020 Feb; 154():108530. PubMed ID: 31678136
[TBL] [Abstract][Full Text] [Related]
42. Betulinic acid: a promising anticancer candidate.
Eiznhamer DA; Xu ZQ
IDrugs; 2004 Apr; 7(4):359-73. PubMed ID: 15057642
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of betulinic acid derivatives with activity against human melanoma.
Kim DS; Pezzuto JM; Pisha E
Bioorg Med Chem Lett; 1998 Jul; 8(13):1707-12. PubMed ID: 9873420
[TBL] [Abstract][Full Text] [Related]
44. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
[TBL] [Abstract][Full Text] [Related]
45. Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization.
Bache M; Bernhardt S; Passin S; Wichmann H; Hein A; Zschornak M; Kappler M; Taubert H; Paschke R; Vordermark D
Int J Mol Sci; 2014 Oct; 15(11):19777-90. PubMed ID: 25361208
[TBL] [Abstract][Full Text] [Related]
46. Betulinic acid inhibits aminopeptidase N activity.
Melzig MF; Bormann H
Planta Med; 1998 Oct; 64(7):655-7. PubMed ID: 9810272
[TBL] [Abstract][Full Text] [Related]
47. Enhancing the divergent activities of betulinic acid via neoglycosylation.
Goff RD; Thorson JS
Org Lett; 2009 Jan; 11(2):461-4. PubMed ID: 19102682
[TBL] [Abstract][Full Text] [Related]
48. New 3-O-acyl betulinic acids from Strychnos vanprukii Craib.
Nguyen QC; Nguyen VH; Santarsiero BD; Mesecar AD; Nguyen MC; Soejarto DD; Pezzuto JM; Fong HH; Tan GT
J Nat Prod; 2004 Jun; 67(6):994-8. PubMed ID: 15217281
[TBL] [Abstract][Full Text] [Related]
49. Protective effects of betulin and betulinic acid against ethanol-induced cytotoxicity in HepG2 cells.
Szuster-Ciesielska A; Kandefer-Szerszeń M
Pharmacol Rep; 2005; 57(5):588-95. PubMed ID: 16227641
[TBL] [Abstract][Full Text] [Related]
50. Antiprotozoal activity of betulinic acid derivatives.
Domínguez-Carmona DB; Escalante-Erosa F; García-Sosa K; Ruiz-Pinell G; Gutierrez-Yapu D; Chan-Bacab MJ; Giménez-Turba A; Peña-Rodríguez LM
Phytomedicine; 2010 Apr; 17(5):379-82. PubMed ID: 19748254
[TBL] [Abstract][Full Text] [Related]
51. Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
Genet C; Strehle A; Schmidt C; Boudjelal G; Lobstein A; Schoonjans K; Souchet M; Auwerx J; Saladin R; Wagner A
J Med Chem; 2010 Jan; 53(1):178-90. PubMed ID: 19911773
[TBL] [Abstract][Full Text] [Related]
52. Enhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: possibility of a new mode of cell killing.
Noda Y; Kaiya T; Kohda K; Kawazoe Y
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1665-70. PubMed ID: 9353895
[TBL] [Abstract][Full Text] [Related]
53. Recent Achievements in Medicinal and Supramolecular Chemistry of Betulinic Acid and Its Derivatives
Bildziukevich U; Özdemir Z; Wimmer Z
Molecules; 2019 Sep; 24(19):. PubMed ID: 31574991
[TBL] [Abstract][Full Text] [Related]
54. Self assembled nano fibers of betulinic acid: A selective inducer for ROS/TNF-alpha pathway mediated leukemic cell death.
Dash SK; Chattopadhyay S; Dash SS; Tripathy S; Das B; Mahapatra SK; Bag BG; Karmakar P; Roy S
Bioorg Chem; 2015 Dec; 63():85-100. PubMed ID: 26469741
[TBL] [Abstract][Full Text] [Related]
55. Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia.
Waechter F; da Silva GNS; Willig JB; de Oliveira CB; Vieira BD; Trivella DBB; Zimmer AR; Buffon A; Pilger DA; Gnoatto SCB
Anticancer Agents Med Chem; 2017; 17(13):1777-1785. PubMed ID: 28403779
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and anticancer activity of novel betulinic acid and betulin derivatives.
Kommera H; Kaluderović GN; Kalbitz J; Paschke R
Arch Pharm (Weinheim); 2010 Aug; 343(8):449-57. PubMed ID: 20726008
[TBL] [Abstract][Full Text] [Related]
57. Betulinic acid as a potent and complex antitumor phytochemical: a minireview.
Gheorgheosu D; Duicu O; Dehelean C; Soica C; Muntean D
Anticancer Agents Med Chem; 2014; 14(7):936-45. PubMed ID: 24568161
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, and anti-tumor activity of novel betulinic acid derivatives.
Liu JH; Tang J; Zhu ZF; Chen L
J Asian Nat Prod Res; 2014 Jan; 16(1):34-42. PubMed ID: 24350921
[TBL] [Abstract][Full Text] [Related]
59. New ionic derivatives of betulinic acid as highly potent anti-cancer agents.
Suresh C; Zhao H; Gumbs A; Chetty CS; Bose HS
Bioorg Med Chem Lett; 2012 Feb; 22(4):1734-8. PubMed ID: 22264477
[TBL] [Abstract][Full Text] [Related]
60. Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy.
Ali-Seyed M; Jantan I; Vijayaraghavan K; Bukhari SN
Chem Biol Drug Des; 2016 Apr; 87(4):517-36. PubMed ID: 26535952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
